|
|
【LYC 0075 交流专区】(前名 MEXTER)
[复制链接]
|
|
|
发表于 2-5-2020 07:21 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2019 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2019 | 31 Dec 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 3,597 | 1,807 | 9,336 | 5,133 | | 2 | Profit/(loss) before tax | -2,207 | -2,200 | -5,852 | -5,287 | | 3 | Profit/(loss) for the period | -2,204 | -514 | -5,845 | -3,597 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -2,056 | -520 | -5,593 | -3,628 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.61 | -0.16 | -1.70 | -1.22 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0600 | 0.0700
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 18-5-2020 07:48 AM
|
显示全部楼层
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Placement Shares issued pursuant to the Proposed Private Placement | No. of shares issued under this corporate proposal | 15,100,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.2300 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 355,364,340 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 67,371,404.480 | Listing Date | 27 Mar 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 24-5-2020 07:54 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | MUTUAL TERMINATION OF THE CONSULTANCY AND PROJECT MANAGEMENT AGREEMENT DATED 30 OCTOBER 2018 BETWEEN LYC LIVING SDN BHD ("LYCL"), A 70% OWNED SUBSIDIARY OF LYC HEALTHCARE BERHAD ("LYC" OR "THE COMPANY") AND LYC WELLNESS SDN BHD (FORMERLY KNOWN AS LYC VENTURE SDN BHD) ("LYCW") (REFERRED AS "AGREEMENT") | The Board of Directors of the Company (“Board”) wishes to announce the mutual termination of the Agreement between LYCL and LYCW.
On 30 October 2018, LYCL had entered into the Agreement with LYCW for the provision of general consultancy, advise and project management by LYCL to LYCW to facilitate the construction, sale and development of LYC Wellness Valley, an integrated health and wellness hub located at Genting Sempah.
The Agreement is conditional upon, amongst others, procuring the necessary approvals from the relevant authorities. As at to-date, the necessary approvals from the relevant authorities have yet to be obtained, in particular the development order and the building plans approval for the LYC Wellness Valley, despite various efforts had been made.
Pursuant to the above and coupled with the current challenging market condition, LYCL and LYCW had mutually agreed in writing to terminate the Agreement on 9 April 2020.
This announcement is dated 9 April 2020.
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 25-5-2020 06:14 AM
|
显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)Particulars of Substantial Securities HolderName | GUNUNG RESOURCES SDN BHD | Address | D-3-3, Block D, Ayer@8, Jalan P8G, Presint 8
Putrajaya
62250 Wilayah Persekutuan
Malaysia. | Company No. | 71881-T | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name & address of registered holder | Gunung Resources Sdn Bhd D-3-3, Block D, Ayer@8, Jalan P8G, Presint 8, 62250 Putrajaya, Malaysia. |
| Date interest acquired & no of securities acquired | Date interest acquired | 07 Apr 2020 | No of securities | 2,367,300 | Circumstances by reason of which Securities Holder has interest | Acquisition of shares from open market. | Nature of interest | Direct Interest |  | | Total no of securities after change | Direct (units) | 18,930,800 | Direct (%) | 5.33 | Indirect/deemed interest (units) |
| | Indirect/deemed interest (%) |
| | Date of notice | 10 Apr 2020 | Date notice received by Listed Issuer | 10 Apr 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 1-6-2020 07:19 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR "THE COMPANY")- Incorporation of a New Sub-Subsidiary Company, LYC Medicare (Singapore) Pte. Ltd. | The Board of Directors of LYC wishes to announce that LYC Medicare Sdn. Bhd., a wholly-owned subsidiary of the Company had on 28 April 2020, incorporated a wholly-owned subsidiary known as LYC Medicare (Singapore) Pte. Ltd. ("LYCMS").
The intended principal activity of LYCMS is to engage in the business related to healthcare services.
The above incorporation does not have any effect on the share capital of the Company and has no material effect on the earnings and net assets of the Company and its subsidiaries for the financial year ending 31 March 2021.
None of the directors and/or substantial shareholders of the Company, or persons connected to such director and/or substantial shareholder has any interest, direct or indirect, in the said incorporation.
This announcement is dated 28 April 2020.
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 2-6-2020 06:28 AM
|
显示全部楼层
本帖最后由 icy97 于 11-7-2021 10:53 AM 编辑
Type | Announcement | Subject | MULTIPLE PROPOSALS | Description | LYC HEALTHCARE BERHAD ("LYC OR THE "COMPANY")I. PROPOSED ACQUISITION BY LYC MEDICARE SDN BHD ("LYC MEDICARE" OR "PURCHASER"), A WHOLLY-OWNED SUBSIDIARY OF LYC, OF A 51% EQUITY INTEREST IN T&T MEDICAL GROUP PTE LTD FOR A PURCHASE CONSIDERATION OF SGD7,293,000; AND II. PROPOSED PRIVATE PLACEMENT OF UP TO 30% OF THE TOTAL NUMBER OF ISSUED SHARES OF LYC AT AN ISSUE PRICE TO BE DETERMINED AND ANNOUNCED LATER(COLLECTIVELY REFERRED TO AS THE "PROPOSALS") | On behalf of the Board of Directors of LYC ("Board"), UOB Kay Hian Securities (M) Sdn Bhd ("UOBKH") wishes to announce that the Company proposes to undertake the following:- i. acquisition by LYC Medicare of a 51% equity interest in T&T Medical Group Pte Ltd ("T&T") at a purchase consideration of SGD7,293,000 (equivalent to RM22,272,822) to be satisfied via a combination of (a) cash amounting to SGD5,304,000 (equivalent to RM16,198,416) and (b) issuance of 1,989,000 redeemable non-cumulative preference shares in LYC Medicare ("RPS") amounting to SGD1,989,000 (equivalent to RM6,074,406), on the terms and conditions contained in the SSA ("Proposed Acquisition"); and
ii. private placement of up to 30% of the total number of issued shares of LYC at an issue price to be determined and announced later ("Proposed Private Placement").
The above are collectively referred to as the "Proposals". Further details of the Proposals are set out in the attachment enclosed.
This announcement is dated 4 May 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3048095
Type | Announcement | Subject | MULTIPLE PROPOSALS | Description | LYC HEALTHCARE BERHAD ("LYC OR THE "COMPANY")I. PROPOSED PRIVATE PLACEMENT II. PROPOSED ACQUISITION OF T&T MEDICAL GROUP PTE LTD III. PROPOSED ACQUISITION OF HC ORTHOPAEDIC SURGERY PTE LTD(COLLECTIVELY REFERRED TO AS THE "PROPOSALS") | The terms used herein, unless the context otherwise stated, bear the same meaning as those defined in the earlier announcements in relation to the Proposals. We refer to the earlier announcements dated 4 May 2020, 28 May 2020, 30 June 2020, 3 July 2020, 27 August 2020, 30 October 2020 and 13 November 2020 in relation to the Proposals.
On behalf of the Board, UOBKH wishes to announce that all the conditions precedent under the SSA HCOS have been fulfilled, and with the full settlement of the purchase consideration in accordance with the terms of the SSA HCOS, the completion of the Proposed Acquisition of HCOS has taken place on 2 December 2020.
This announcement is dated 2 December 2020. |
Type | Announcement | Subject | OTHERS | Description | PRESS RELEASE ON THE COMPLETION OF THE ACQUISITIONS OF 51% EQUITY INTEREST IN T&T MEDICAL GROUP PTE LTD AND HC ORTHOPAEDIC SURGERY PTE LTD | Please find attached LYC Healthcare Berhad's press release in relation to the subject matter. Further details of the aforesaid press release are set out in the attachment enclosed.
This announcement is dated 2 December 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3110716
|
|
|
|
|
|
|
|
|
|
|
|
发表于 6-6-2020 06:50 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR "THE COMPANY")COVID-19 CONTACT TRACING COLLABORATION AGREEMENT BETWEEN LYC MEDICARE SDN BHD (LYC MEDICARE) AND FORWEN SDN BHD (FORWEN) TO MARKET A COVID-19 CONTACT TRACING APPLICATION IN MALAYSIA ("COLLABORATION AGREEMENT") | The Board of Directors of LYC wishes to announce that LYC Medicare Sdn Bhd [Registration No. 200501003142 (680188-M)], a wholly-owned subsidiary of the Company, had on 14 May 2020 entered into a Covid-19 Contact Tracing Collaboration Agreement with Forwen Sdn Bhd [Registration No. 200501024842 (706975-U)] to market an application called the “Forwen Tracker” to centralise Big Data system with a simple and fast combination of web application as well as Android and iOS application for data collection in relation to the Covid-19 outbreak.
Kindly refer to the attached announcement on the Collaboration Agreement.
This announcement is dated 14 May 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3050191
|
|
|
|
|
|
|
|
|
|
|
|
发表于 7-6-2020 08:43 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR "THE COMPANY") HYGIENE AND DISINFECTION SERVICES COLLABORATION AGREEMENT BETWEEN LYC MEDICARE SDN BHD ("LYC MEDICARE") AND BIOFRESH HYGIENE SERVICES SDN BHD ("BIOFRESH") TO MARKET CLEANLINESS, HYGIENE AND SANITATION SERVICES IN MALAYSIA ("COLLABORATION AGREEMENT") | The Board of Directors of LYC wishes to announce that LYC Medicare Sdn Bhd [Registration No. 200501003142 (680188-M)], a wholly-owned subsidiary of the Company, had on 18 May 2020 entered into a Hygiene and Disinfection Services Collaboration Agreement with Biofresh Hygiene Services Sdn Bhd [Registration No. 200601028192 (747948-D)] to market a range of cleanliness, hygiene and sanitation services including manual and automatic hand sanitizer dispensers, hand soap dispenser, toilet seat sanitizer, lady bin as well as disinfection service, on behalf of Biofresh.
Kindly refer to the attached announcement on the Collaboration Agreement.
This announcement is dated 18 May 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3051005
|
|
|
|
|
|
|
|
|
|
|
|
发表于 8-6-2020 07:32 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY") - INCORPORATION OF A 51% OWNED SUBSIDIARY | 1. Introduction
The Board of Directors of LYC wishes to announce that the Company has on 19 May 2020 incorporated a Fifty-One percent (51%) owned subsidiary known as KLIMC Sdn Bhd [Registration No. 202001011665 (1367985-V)]("KLIMC"). The remaining Forty-Nine percent (49%) shareholding is held by Urban Masterpiece Sdn Bhd [Registration No. 201601027097 (1198036-A)](“Urban Masterpiece”).
2. Information of KLIMC
KLIMC was incorporated on 19 May 2020 as a private limited company by shares in Malaysia under the Companies Act 2016. The share capital of KLIMC as at the date of announcement is Ringgit Malaysia One Hundred (RM100.00) only comprising One Hundred (100) ordinary shares. LYC holds Fifty-One (51) shares for Ringgit Malaysia Fifty-One (RM51.00) only, representing Fifty-One percent (51%) shareholding of KLIMC while Urban Masterpiece holds Forty-Nine (49) shares for Ringgit Malaysia Forty-Nine (RM49.00) only, representing Forty-Nine percent (49%) shareholding of KLIMC.
The intended principal activities of KLIMC are to own and to carry on the business of running hospitals.
The current directors of KLIMC are Mr Sui Diong Hoe and Dr. Nor Azeera Binti Wahab.
3. Information of Urban Masterpiece
Urban Masterpiece is a Malaysian company with business interest in water treatment technology, flood mitigation infrastructures, security and defense solutions.
The share capital of Urban Masterpiece is One Million Ringgit (RM1,000,000) only comprising One Million (1,000,000) ordinary shares. The shareholders and directors of Urban Masterpiece are Encik Mohamad Shohor bin Mahamud and Datuk Wan Abd Halim bin Abd Majid who holds five hundred thousand (500,000) shares each respectively.
The founders, shareholders, directors and advisors of the company are having more than 25 years of working experience ranging from architectural design, real estate development, construction, aerostructure composite manufacturing and aerospace engineering services.
4. Rationale
The Company is working with Urban Masterpiece to explore the possibility of set up, own and operate a hospital with a focus on attracting medical tourism with a focus on fertility, cosmetic and aesthetic, orthopaedic and osteperosis at a location to be identified at a later date and is subject to approval of necessary authorities.
According to the Malaysia Healthcare Travel Council, the healthcare travel industry in Malaysia grew by 14% in 2019 with recorded RM1.5 billion in receipts from 1.2 million medical tourists.
The Company intends to leverage on the healthcare expertise of LYC Healthcare group of companies and the construction expertise of Urban Masterpiece to ensure the successful execution of the proposed project.
5. Financial Effect of the Incorporation of KLIMC
The incorporation of KLIMC does not have any effect on the share capital and substantial shareholders’ shareholdings of LYC. It is also not expected to have any material effect on the net assets, gearing and earnings of LYC for the financial year ending 31 March 2021.
6. Directors’ and Major Shareholders’ Interests
None of the directors and/or major shareholders of the Company, or persons connected to such directors and/or major shareholders, has any interest, direct or indirect, in the said incorporation.
This announcement is dated 19 May 2020.
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 15-6-2020 07:12 AM
|
显示全部楼层
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | LYC HEALTHCARE BERHAD ("LYC OR THE "COMPANY")PROPOSED ACQUISITION BY LYC MEDICARE SDN BHD ("LYC MEDICARE" OR "PURCHASER"), A WHOLLY-OWNED SUBSIDIARY OF LYC, OF A 51% EQUITY INTEREST IN HC ORTHOPAEDIC SURGERY PTE LTD FOR A PURCHASE CONSIDERATION OF SGD6,936,000 | On behalf of the Board of Directors of LYC ("Board"), UOB Kay Hian Securities (M) Sdn Bhd ("UOBKH") wishes to announced that LYC Medicare, a wholly-owned subsidiary of LYC, had on 28 May 2020 entered into a conditional share sale agreement ("SSA") with Chan Ying Ho and Beyond Wellness Group Pte Ltd ("BWG") ("Vendors") for the proposed acquisition by LYC Medicare of a 51% equity interest in HC Orthopaedic Surgery Pte Ltd ("HCOS") for a purchase consideration of SGD6,936,000 (equivalent to RM21,293,520) to be satisfied entirely in cash, on the terms and conditions contained in the SSA ("Proposed Acquisition").
Further details of the Proposed Acquisition are set out in the attachment enclosed.
This announcement is dated 28 May 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3053569
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-9-2020 10:13 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Mar 2020 | 31 Mar 2019 | 31 Mar 2020 | 31 Mar 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 3,098 | 2,470 | 12,434 | 7,603 | | 2 | Profit/(loss) before tax | -4,309 | -2,238 | -10,161 | -7,525 | | 3 | Profit/(loss) for the period | -4,424 | -2,300 | -10,269 | -5,897 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -4,050 | -2,253 | -9,643 | -5,881 | | 5 | Basic earnings/(loss) per share (Subunit) | -1.19 | -0.69 | -2.91 | -1.97 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0600 | 0.0700
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 29-11-2020 10:07 AM
|
显示全部楼层
Date of change | 04 Aug 2020 | Name | DATO' LIM CHENG POH | Age | 71 | Gender | Male | Nationality | Malaysia | Designation | Chairman | Directorate | Independent and Non Executive | Type of change | Resignation | Reason | To pursue his own personal interests. | Details of any disagreement that he/she has with the Board of Directors | No | Whether there are any matters that need to be brought to the attention of shareholders | No |
QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information |
Working experience and occupation | N/A | Family relationship with any director and/or major shareholder of the listed issuer | None | Any conflict of interests that he/she has with the listed issuer | None | Details of any interest in the securities of the listed issuer or its subsidiaries | Indirect interest of 1,600,000 ordinary shares. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 5-1-2021 08:38 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Jun 2020 | 30 Jun 2019 | 30 Jun 2020 | 30 Jun 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 2,628 | 2,686 | 2,628 | 2,686 | | 2 | Profit/(loss) before tax | -2,708 | -1,592 | -2,708 | -1,592 | | 3 | Profit/(loss) for the period | -2,706 | -1,590 | -2,706 | -1,590 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -2,576 | -1,543 | -2,576 | -1,543 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.72 | -0.47 | -0.72 | -0.47 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0500 | 0.0700
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 15-2-2021 05:52 AM
|
显示全部楼层
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | LYC HEALTHCARE BERHAD ("LYC OR THE "COMPANY")I. SUBSCRIPTION BY LYC MEDICARE SDN BHD (A WHOLLY-OWNED SUBSIDIARY OF LYC) OF 30% EQUITY INTEREST IN SEL STEM SDN BHD ("SEL STEM"); ANDII. SHAREHOLDERS' AGREEMENT BETWEEN LYC MEDICARE SDN BHD, ALL LIFE ADVANCE IMMUNOLOGY SDN BHD, LIEF CAPITAL SDN BHD AND KHOO TOH HOCK | The Board of Directors of LYC ("Board"), wishes to announce that LYC Medicare Sdn Bhd ("LYC Medicare"), a wholly-owned subsidiary of LYC, had on 1 October 2020 subscribed for 300,000 new ordinary shares in Sel Stem, representing 30% equity interest in Sel Stem, for a cash consideration of RM300,000 ("Subscription"). In conjunction thereto, LYC Medicare, had on even date entered into a shareholders' agreement with All Life Advance Immunology Sdn Bhd ("ALAI"), Lief Capital Sdn Bhd ("LIEF") and Khoo Toh Hock ("KTH") to regulate their rights and obligations as shareholders of Sel Stem and in respect of the management and business affairs of Sel Stem ("SHA"). The business of Sel Stem shall be the making of a proposed investment in the ordinary shares of Advanced Neuroscience & Orthopaedic Clinic Sdn Bhd ("ANOC"), which is principally involved in the provision of consultancy services in medical and healthcare related fields including the sale of pharmaceutical products.
Please refer to the attachment for further details.
This announcement is dated 1 October 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3092827
|
|
|
|
|
|
|
|
|
|
|
|
发表于 8-3-2021 07:39 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY") - PROPOSED ISSUANCE OF UP TO 45,000,000 NEW REDEEMABLE PREFERENCE SHARES ("RPS") BY LYC MEDICARE SDN BHD, A WHOLLY OWNED SUBSIDIARY OF LYC, TO KENANGA INVESTORS BERHAD AT AN ISSUE PRICE OF RM1.00 PER RPS ("PROPOSED ISSUANCE OF RPS") | The Board of Directors of LYC wishes to announce that LYC Medicare Sdn Bhd [Registration No. 200501003142 (680188-M)] ("LYC Medicare"), a wholly-owned subsidiary of LYC, proposes to undertake the Proposed Issuance of RPS.
On even date, the Company entered into a conditional subscription agreement with Kenanga Investors Berhad [Registration No.: 199501024358 (353563-P)] and LYC Medicare in relation to the Proposed Issuance of RPS.
Kindly refer to the attached announcement on the Proposed Issuance of RPS.
This announcement is dated 15 October 2020.
|
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3096699
|
|
|
|
|
|
|
|
|
|
|
|
发表于 14-5-2021 10:22 AM
|
显示全部楼层
本帖最后由 icy97 于 12-8-2021 07:10 AM 编辑
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY") - ACQUISITION OF 49% SHAREHOLDING FROM XING DAO INTERNATIONAL PTE. LTD. IN LYC COSMETIC & AESTHETIC SDN BHD, A 51% OWNED SUBSIDIARY OF THE COMPANY | Reference is made to the Company’s announcement dated 30 April 2019 in relation to the incorporation of a subsidiary company, the Board of Directors of LYC wishes to announce that LYC has on 5 November 2020 acquired Forty-Nine (49) ordinary shares in the share capital of LYC Cosmetic & Aesthetic Sdn Bhd [Registration No. 201901015380 (1324708-T)] ("LYC Cosmetic"), which representing Forty-Nine percent (49%) of LYC Cosmetic’s ordinary shares from Xing Dao International Pte. Ltd. (Company No. 201801391W) for a cash consideration of Ringgit Malaysia Forty-Seven Thousand Five Hundred Thirty-Five and Sixty-Seven Cents (RM47,535.67) only.
That upon the completion of the acquisition, LYC Cosmetic has become a wholly-owned subsidiary of LYC.
The acquisition is not expected to have any material financial or operational impact on the Company for the financial year ending 31 March 2021.
This announcement is dated 6 November 2020.
|
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY") - INCORPORATION OF A 65% OWNED SUBSIDIARY | 1. Introduction
The Board of Directors of LYC wishes to announce that Mexter (M) Sdn Bhd (“Mexter”), a wholly-owned subsidiary of the Company had on 12 November 2020, incorporated a Sixty-Five percent (65%) owned subsidiary known as Mexter DC Sdn. Bhd. [Registration No. 202001036787 (1393108-X)](“Mexter DC”). The remaining Thirty-Five percent (35%) shareholding is held by Cloud Asia Sdn. Bhd. [Registration No. 202001035382 (1391703-K)](“Cloud Asia”).
2. Information of Mexter DC
Mexter DC was incorporated on 12 November 2020 as a private limited company by shares in Malaysia under the Companies Act, 2016. The share capital of Mexter DC as at the date of announcement is Ringgit Malaysia One Thousand Only (RM1,000.00) comprising One Thousand (1,000) ordinary shares. Mexter holds Six Hundred Fifty (650) shares for Ringgit Malaysia Six Hundred Fifty only (RM650.00), representing Sixty-Five percent (65%) shareholding of Mexter DC while Cloud Asia holds Three Hundred Fifty (350) shares for Ringgit Malaysia Three Hundred Fifty only (RM350.00), representing 35% shareholding of Mexter DC.
The intended principal activities of Mexter DC are to carry on the activities of providing infrastructure for hosting, data processing services and related activities, data processing activities and research and development on Information Communication Technology (ICT).
The current director of Mexter DC is Mr Sui Diong Hoe.
3. Information of Cloud Asia
Cloud Asia is a private limited company by shares in Malaysia under the Companies Act, 2016 and is wholly-owned by Chong Yoke Beey (“Yoke Beey”). The issued share capital of Cloud Asia is Ringgit Malaysia One Hundred only (RM100.00) comprising One Hundred (100) ordinary shares. Yoke Beey is the sole director of Cloud Asia.
4. Rationale
The Company via Mexter DC will explore data centre related projects in Malaysia and will look to leverage on Cloud Asia’s expertise to determine the viability of any prospective projects. The Company believes Malaysia is well positioned to become the next data center hub in the region, given the availability of land, cheap power tariffs, excellent infrastructure, availability of talent and strong support from the government. Additionally, the Company expects Malaysia to gain traction for data center investments owing to the land shortage faced by Singapore to facilitate greenfield developments. The expansion by hyperscale across other Southeast Asian countries is likely to lead to an increase in investments in Malaysia.
5. Financial Effect of the Incorporation of Mexter DC
The incorporation of Mexter DC does not have any effect on the share capital and substantial shareholders’ shareholdings of LYC. It is also not expected to have any material effect on the net assets, gearing and earnings of LYC for the financial year ending 31 March 2021.
6. Directors’ and Major Shareholders’ Interests
None of the Directors and/or major shareholders of LYC or persons connected with them, have any direct or indirect interest in the incorporation of Mexter DC.
This announcement is dated 12 November 2020. |
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2020 | 30 Sep 2019 | 30 Sep 2020 | 30 Sep 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 3,876 | 3,053 | 6,504 | 5,739 | | 2 | Profit/(loss) before tax | -3,017 | -2,053 | -5,725 | -3,645 | | 3 | Profit/(loss) for the period | -3,015 | -2,051 | -5,721 | -3,641 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -2,863 | -1,994 | -5,439 | -3,537 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.80 | -0.61 | -1.53 | -1.09 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0500 | 0.0700
|
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Private Placement of up to 30% of the issued shares of LYC Healthcare Berhad | No. of shares issued under this corporate proposal | 4,920,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.3050 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 368,225,740 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 71,699,308.480 | Listing Date | 28 Dec 2020 |
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR "THE COMPANY")EXECUTION OF A NON-BINDING MEMORANDUM OF UNDERSTANDING BETWEEN MEXTER DC SDN BHD, A SIXTY-FIVE PERCENT (65%) OWNED ENTITY OF MEXTER (M) SDN BHD, A WHOLLY OWNED SUBSIDIARY OF THE COMPANY AND EMPYRION DC PTE LTD FOR THE DEVELOPMENT OF TWO (2) GREENFIELD PURPOSE BUILT TO SUITE DATA CENTRE IN JOHOR, MALAYSIA ("DC MOU") | 1. INTRODUCTION
The Board wishes to announce that Mexter DC Sdn Bhd [Registration No. 202001036787 (1393108-X)] (“Mexter DC”) had on 24 December 2020 entered into a non-binding memorandum of understanding with Empyrion DC Pte Ltd (Registration No. 202013809K) (“Empyrion DC”) to pursue the consultancy, engineering, procurement and construction of two (2) greenfield purpose built to suite data centre projects in Johor, Malaysia, subject to the feasibility studies and the finalisation of a mutually acceptable and binding definitive development agreement (“Development Agreement”).
Mexter DC and Empyrion DC are each referred to as the “Party” and collectively referred to as the “Parties”.
2. DETAILS OF THE DC MOU
The DC MOU between the Parties sets out the relationship between both parties and their scope of work and will involve the carrying out of a feasibility study for the set-up of two (2) greenfield data centre projects in Johor, Malaysia (“DC Project”). It is anticipated that Mexter DC will identify the site(s) for Empyrion DC’s consideration and upon satisfaction of the feasibility study, Empyrion DC will enter into the Development Agreement for the DC Project and other relevant transaction documents including documents in relation for the purchase of the land by a special purpose entity.
3. INFORMATION ON EMPYRION DC
Empyrion DC is a private limited company incorporated under the laws of Singapore on 18 May 2020. It is principally involved in data centre operations and its related services.
4. RATIONALE FOR THE DC MOU
The DC MOU allows the Parties to outline the parameters of the definitive Development Agreement and sets out the understanding and intention in respect of the DC Project.
The Company believes Malaysia is well positioned to become the next data center hub in the region, given the availability of land, cheap power tariffs, excellent infrastructure, availability of talent and strong support from the government. Additionally, the Company expects Malaysia to gain traction for data center investments in the region owing to the land shortage faced by Singapore to facilitate greenfield developments.
5. FINANCIAL EFFECTS
Pending the signing of the Development Agreement, the DC MOU is not expected to have any material effects on the issued share capital and substantial shareholders’ shareholdings of the Company, net assets, gearing, earnings and net earnings per share of the Group.
6. APPROVALS REQUIRED
The execution of the DC MOU does not require the approval of shareholders of the Company or any relevant authorities.
This announcement is dated 24 December 2020. |
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)Particulars of Substantial Securities Holder
Name | TEE CHEE CHIANG | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | Alliancegroup Nominees (Tempatan) Sdn Bhd - Pledge Securites Account for Tee Chee Chiang |
| Date interest acquired & no of securities acquired | Date interest acquired | 24 Dec 2020 | No of securities | 387,000 | Circumstances by reason of which Securities Holder has interest | Acquisition of shares from open market. | Nature of interest | Direct Interest | | | Total no of securities after change | Direct (units) | 18,706,600 | Direct (%) | 5.08 | Indirect/deemed interest (units) |
| | Indirect/deemed interest (%) |
| | Date of notice | 31 Dec 2020 | Date notice received by Listed Issuer | 31 Dec 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 16-10-2021 11:56 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR "THE COMPANY") - INCORPORATION OF A WHOLLY OWNED SUBSIDIARY BY LYC SOG MOTHER & CHILD SDN BHD, A FIFTY-ONE PERCENT (51%) OWNED SUB-SUBSIDIARY OF THE COMPANY | 1. INTRODUCTION
The Board of Directors of LYC wishes to announce that LYC SOG Mother & Child Sdn Bhd [Registration No. 202101013590 (1413889-W) (“LYCSOG”), a fifty-one percent (51%) owned sub-subsidiary of the Company had on 15 October 2021 incorporated a wholly owned-subsidiary in Singapore known as LYC SOG Marketing Pte. Ltd. [Registration No. 202135923W] (“LYC SOG Marketing”).
2. INFORMATION ON LYC SOG MARKETING
LYC SOG Marketing was incorporated on 15 October 2021 as a private limited company by shares in Singapore. The share capital of LYC SOG Marketing as at the date of this announcement is Singapore Dollar One Thousand Only (RM1,000.00) comprising One Thousand (1,000) ordinary shares. LYCSOG holds One Thousand (1,000) shares for Singapore Dollar One Thousand only (RM1,000.00), representing One Hundred percent (100%) shareholding of LYC SOG Marketing.
The intended principal activity of LYC SOG Marketing is provision of marketing and promotional services related to the confinement centres and mother and child care centres.
The current director of LYC SOG Marketing is Mr Choo Kok Wei, Eric.
3. INFORMATION ON LYCSOG
LYCSOG was incorporated on 13 April 2021 as a private limited company by shares in Malaysia under the Companies Act, 2016. The share capital of LYCSOG as at the date of this announcement is Ringgit Malaysia Four Million (RM4,000,000.00) comprising Four Million (4,000,000) ordinary shares. LYC Mother and Child Centre Sdn Bhd [Registration No. 201101044567 (972687-K) (“LYCMC”) holds Two Million and Forty Thousand (2,040,000) ordinary shares for Ringgit Malaysia Two Million and Forty Thousand only (RM2,040,000.00), representing Fifty-One percent (51%) shareholding of LYCSOG while SOG Mummy & Baby Centre Pte Ltd [Registration No. 202111133M] (“SOGMB”) holds One Million Nine Hundred and Sixty Thousand (1,960,000) ordinary shares for Ringgit Malaysia One Million Nine Hundred and Sixty Thousand only (RM1,960,000.00), representing Forty-Nine percent (49%) shareholding of LYCSOG. SOGMB is a wholly-owned subsidiary of Singapore O&G Ltd [Registration No. 201100687M] (“SOG”).
The intended principal activities of LYCSOG are to operate confinement centres, mother and child care centres and its related services.
The current directors of LYCSOG are Mr Sui Diong Hoe, Encik Ahmad Rafique bin Mat Tahir, Dr Yang Jun, Dr Heng Tung Lan and Mr Choo Kok Wei, Eric.
4. INFORMATION ON SOGMB & SOG
SOGMB is a private company limited by shares and was incorporated on 30 March 2021. The issued share capital of SOGMB is Singapore Dollar $1,000.00 comprising 1,000 ordinary shares. The current directors of SOGMB are Dr. Beh Suan Tiong, Dr. Heng Tung Lan and Mr Choo Kok Wei, Eric.
The principal activity of SOGMB is as an investment holding company.
SOG is a company incorporated in the Republic of Singapore. The issued share capital of SOG is Singapore Dollar S$29,808,833 comprising 476,803,002 ordinary shares. The current directors of SOG are Dr. Beh Suan Tiong, Dr. Heng Tung Lan, Dr. Lee Keen Whye, Mr. Ng Boon Yew, Ms. Linda Hoon Siew Kin and Ms. See Tho Soat Ching.
Established since 2011, SOG is a leading healthcare service provider dedicated towards delivering premier quality medical services to women’s and children’s health and wellness at affordable prices. SOG was listed on the Catalist board of the Singapore Exchange Securities Trading Limited since 2015.
5. RATIONALE
The incorporation of LYC SOG Marketing is to facilitate the marketing and promotional services in Singapore on behalf of LYCSOG. LYCSOG is currently in the midst of setting up a confinement centre in Johor, Malaysia.
The proposed Johor confinement centre’s close proximity to Singapore would mean that the proposed confinement centre in Johor would be able to tap into Singapore market with live births of 39,115 (as at 2019) per annum based on the Singapore Demographic Bulletin under Singapore’s Immigration & Checkpoints Authority.
According to the Singapore’s Department of Statistics, 74.3% of its population are from the Chinese ethnic group, which typically practice confinement period after the delivery of their babies. LYC believes that the proposed new confinement centre in Johor will be an attractive alternative for both the Singaporean and Malaysian customers who wish to spend their post childbirth confinement period in the state of Johor.
The joint venture between LYC and SOG via LYCSOG enables LYC to rely on SOG’s strong branding and presence in Singapore to reach out and serve the Singaporean customers while LYCMC leverages on its established track record in confinement business to set up and manage the proposed confinement centre in Johor.
6. FINANCIAL EFFECT OF THE INCORPORATION OF LYC SOG MARKETING
The incorporation of LYC SOG Marketing does not have any effect on the share capital and substantial shareholders’ shareholdings of LYC. It is also not expected to have any material effect on the net assets, gearing and earnings of LYC for the financial year ending 31 March 2022.
7. DIRECTORS’ AND MAJOR SHAREHOLDERS’ INTERESTS
None of the Directors and/or major shareholders of LYC or persons connected with them, have any direct or indirect interest in the incorporation of LYC SOG Marketing.
This announcement is dated 15 October 2021.
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 17-11-2021 07:27 AM
|
显示全部楼层
Notice of Person Ceasing (Section 139 of CA 2016)Particulars of Substantial Securities HolderName | EXEMPT AN FOR KENANGA INVESTORS BERHAD | Address | Level 14, Kenanga Tower, 237, Jalan Tun Razak
Kuala Lumpur
50400 Wilayah Persekutuan
Malaysia. | Company No. | 199501024358 (353563-P) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | Citigroup Nominees (Tempatan) Sdn Bhd - Exempt AN For Kenanga Investors Berhad | Address of registered holder | Level 42, Menara Citibank, 165, Jalan Ampang, 50450 Kuala Lumpur. | Date of cessation | 01 Nov 2021 |
No of securities disposed | 50,000,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Transfer of shares. | Nature of interest | Direct Interest | | Date of notice | 02 Nov 2021 | Date notice received by Listed Issuer | 02 Nov 2021 |
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)Particulars of Substantial Securities HolderName | EXEMPT AN FOR KENANGA ISLAMIC INVESTORS BERHAD | Address | Level 14, Kenanga Tower, 237, Jalan Tun Razak
Kuala Lumpur
50400 Wilayah Persekutuan
Malaysia. | Company No. | 199701036457 (451957-D) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | Citigroup Nominees (Tempatan) Sdn Bhd - Exempt AN For Kenanga Islamic Investors Berhad | Address of registered holder | Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur. |
| Date interest acquired & no of securities acquired | Date interest acquired | 01 Nov 2021 | No of securities | 50,000,000 | Circumstances by reason of which Securities Holder has interest | Transfer of shares. | Nature of interest | Direct Interest | | | Total no of securities after change | Direct (units) | 50,000,000 | Direct (%) | 11.587 | Indirect/deemed interest (units) |
| | Indirect/deemed interest (%) |
| | Date of notice | 02 Nov 2021 | Date notice received by Listed Issuer | 02 Nov 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 17-11-2021 09:32 AM
|
显示全部楼层
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Private Placement of up to 30% of the issued shares of LYC Healthcare Berhad | No. of shares issued under this corporate proposal | 33,000,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.2470 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 464,525,740 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 95,451,808.480 | Listing Date | 05 Nov 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 28-11-2021 08:06 AM
|
显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)Particulars of Substantial Securities HolderName | EXEMPT AN FOR KENANGA INVESTORS BERHAD | Address | Level 14, Kenanga Tower, 237, Jalan Tun Razak
Kuala Lumpur
50400 Wilayah Persekutuan
Malaysia. | Company No. | 199501024358 (353563-P) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | Citigroup Nominees (Tempatan) Sdn Bhd - Exempt AN For Kenanga Investors Berhad | Address of registered holder | Level 42, Menara Citibank, 165, Jalan Ampang, 50450 Kuala Lumpur. |
| Date interest acquired & no of securities acquired | Date interest acquired | 05 Nov 2021 | No of securities | 30,000,000 | Circumstances by reason of which Securities Holder has interest | Acquired by way of private placement. | Nature of interest | Direct Interest | | | Total no of securities after change | Direct (units) | 30,000,000 | Direct (%) | 6.458 | Indirect/deemed interest (units) |
| | Indirect/deemed interest (%) |
| | Date of notice | 09 Nov 2021 | Date notice received by Listed Issuer | 10 Nov 2021 |
|
|
|
|
|
|
|
|
|
|
| |
本周最热论坛帖子
|
2600 
58
